Evidence map›Paper›PMID 32309436›Full record

ArticleBioMed research international2020

PERK Overexpression-Mediated Nrf2/HO-1 Pathway Alleviates Hypoxia/Reoxygenation-Induced Injury in Neonatal Murine Cardiomyocytes via Improving Endoplasmic Reticulum Stress.

Jichun Wang, Li Lu, Sisi Chen, Jing Xie, Shuai Lu, Yanli Zhou, Hong Jiang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Frontiers in pharmacology · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. The integrated stress response in ischemic diseases.Cell death and differentiation · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jichun WangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.
Li LuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.ORCID https://orcid.org/0000-0002-3905-1273
Sisi ChenDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.
Jing XieDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.
Shuai LuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.
Yanli ZhouDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.
Hong JiangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.ORCID https://orcid.org/0000-0001-5099-868X
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reperfusion processes following acute myocardial infarction (AMI) have been reported to induce additional cardiomyocyte death, known as ischemia-reperfusion (I/R) injury. Endoplasmic reticulum (ER) stress is reported to be involved in the development of I/R injury. There is evidence that PERK exerts beneficial roles in alleviating ER stress. Here, we investigated whether upregulation of PERK improved cardiomyocytes injury induced by I/R. Specific siRNAs or adenovirus vectors were incubated with isolated neonatal cardiomyocytes (NCMs) to regulate expression levels of target genes including PERK, Nrf2, and HO-1. Afterwards, hypoxia and subsequent reoxygenation (H/R) administration was performed as the in vitro model of I/R injury. MTT assay showed that H/R intervention decreased the viability of cells, yet PERK overexpression increased the cellular proliferative rate. Moreover, the upregulation of Nrf2 or HO-1 elevated the growth rate of cells, while gene silencing of Nrf2 or HO-1 reduced the viability of NCMs treated with PERK-rAAV9. In addition, we observed that the apoptotic index of cells with H/R stimulation was reduced when NCMs were pretreated with PERK-rAAV9, Nrf2-rAAV9, or HO-1-rAAV9. After cells were incubated with Nrf2-siRNA or HO-1-siRNA, the upregulation of PERK had no roles in affecting the apoptosis rate of NCMs damaged by H/R. Then, our findings indicated that there was a level decrease of GRP78, CRT, CHOP, and Caspase-12 in NCMs of the PERK-rAAV9 group compared to that of the H/R group. Both Nrf2 overexpression and HO-1 upregulation reduced the expression of ER stress-related proapoptotic factors, yet the expression suppression of Nrf2 and HO-1 increased levels of GRP78, CRT, CHOP, and Caspase-12 in NCMs treated with PERK-rAAV9. Taken together, our results suggested that the effects of PERK against H/R injury might be attributed to the upregulation of Nrf2/HO-1 cascade, followed by the inhibition of ER stress-related apoptotic pathway.

Indexed as

AnimalsApoptosiseIF-2 KinaseEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressGene Expression RegulationHeme Oxygenase-1HypoxiaMembrane ProteinsMiceMyocardial Reperfusion InjuryMyocytes, CardiacNF-E2-Related Factor 2RNA, Small InterferingUp-RegulationeIF-2 KinaseEndoplasmic Reticulum Chaperone BiPHeme Oxygenase-1Hmox1 protein, mouseHspa5 protein, mouseMembrane ProteinsNfe2l2 protein, mouseNF-E2-Related Factor 2RNA, Small Interfering

Identifiers

PMID32309436
PMCPMC7136769
OpenAlexW3013253000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.